Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin

This publication has 34 references indexed in Scilit:

• HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
  Blood, 2003
• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
  Blood, 2003
• Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants
  Transplantation and Cellular Therapy, 2002
• Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone
  Blood, 2002
• Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
  Blood, 2001
• Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs
  Bone Marrow Transplantation, 2001
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
  Blood, 2001
• Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation
  Bone Marrow Transplantation, 2001
• Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice
  Nature Medicine, 1995
• CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S
  Transplantation, 1974